Long-term observational comparison of risperidone and olanzapine in bipolar disorder

Annals of Clinical Psychiatry

Volumn 16, Issue 2, 2004, Pages 69-73

  Ghaemi, S Nassir ^a,b,d   Hsu, Douglas J ^a,b   Rosenquist, Klara J ^a,b   Katzow, Jacob J ^c   Goodwin, Frederick K ^c  

^a Bipolar Disorder Research Program   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d CAMBRIDGE HOSPITAL   (United States)

Author keywords

Bipolar disorder; Drug therapy; Maintenance; Olanzapine; Prophylaxis; Risperidone

Indexed keywords

CARBAMAZEPINE; LITHIUM; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; MALE; MANIA; OBSERVATION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SEDATION; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISPERIDONE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 4043059267     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1080/10401230490453103     Document Type: Article

References (21)

1. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159:1146-1154.
2. Rothman K, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998.
3. Ghaemi SN, Soldani F. Meta-analysis of observational studies in psychiatry: the case of rapid-cycling bipolar disorder. Acta Psychiatry Scand 2003; 108:1-3.
4. Ghaemi SN. New treatments for bipolar disorder: the role of atypical neuroleptic agents. J Clin Psychiatry 2000; 61:33-42.
5. Zarate CA, Jr., Tohen M, Banov MD, Weiss MK, Cole JO. Is clozapine a mood stabilizer? J Clin Psychiatry 1995; 56:108-812.
6. Ghaemi SN. On defining 'mood stabilizer.' Bipolar Disord 2001; 3:154-158.
7. Sachs GS: Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996; 16:32S-47S.
8. Goodwin F, Jamison K. Manic depressive illness. New York: Oxford University Press; 1990.
9. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61:841-850.
10. Ghaemi SN, Sachs GS. Long-term risperidone treatment in bipolar disorder: 6 month follow-up. Int Clin Psychopharmacol 1998; 12:333-338.
11. Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 2001; 62:273-281.
12. Vieta E, Goikolea JM, Corbella B et al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001; 62:818-825.
13. Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush A. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156:1164-1169.
14. Ghaemi SN, Goodwin FK. Use of atypical anti-psychotic agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychopharmacol 1999; 19:354-361.
15. Glazer WM. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 2000; 61:16-21.
16. Sachs GS, Guille C. Weight gain associated with use of psychotropic medications. J Clin Psychiatry 1999; 60:16-19.
17. Masand PS, Wang X, Gupta S, Schwartz TL, Virk S, Hameed A. Comparison of risperidone and olanzapine in bipolar and schizoaffective disorders (abstract). Presented at 22nd CINP Congress, July 9-13, 2000, Brussels, Belgium.
18. IMS: National Disease and Therapeutic Index. New Jersey: IMS America; 2001.
19. Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000; 57:841-849.
20. Tollefson GD, Beasley CM Jr., Tamura RN, Tran PV, Potvin JH. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997; 154:1248-1254.
21. Jeste DV, Okamoto A, Napolitano J, Kane JM, Martinez RA. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry 2000; 157:1150-1155.